{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:39:06Z","timestamp":1790217546615,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003213","name":"Beijing Municipal Education Commission","doi-asserted-by":"publisher","award":["KM202310025023"],"award-info":[{"award-number":["KM202310025023"]}],"id":[{"id":"10.13039\/501100003213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304389"],"award-info":[{"award-number":["82304389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.149478","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:37:45Z","timestamp":1765006665000},"page":"149478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Cancer cell membrane-biomimetic and antioxidant-powered nanoplatform for overcoming multidrug resistance in triple-negative breast cancer"],"prefix":"10.1016","volume":"337","author":[{"given":"Qi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamuhaer","family":"Yelebolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149478_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Hyuna","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149478_bb0010","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Michael A","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149478_bb0015","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Yuanyuan","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149478_bb0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ccell.2025.01.007","article-title":"Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer","volume":"43","author":"Yuanyuan","year":"2025","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149478_bb0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s12276-025-01466-5","article-title":"Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer","volume":"57","author":"Ozlem","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0030","article-title":"Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study","volume":"74","author":"Min","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-023-02677-x","article-title":"Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial","volume":"30","author":"Zefei","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0040","article-title":"Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers","volume":"23","author":"Annamaria","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0045","article-title":"PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy","volume":"16","author":"Iris C","year":"2017","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.149478_bb0050","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood-2018-06-859686","article-title":"Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma","volume":"133","author":"Z.","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149478_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Qi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0060","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Bo","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.actbio.2021.09.002","article-title":"Tumor-targeting pH\/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA","volume":"135","author":"Yuan","year":"2021","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149478_bb0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0075","article-title":"siRNA specificity: RNAi mechanisms and strategies to reduce off-target effects","volume":"11","author":"Julia","year":"2021","journal-title":"Front. Plant Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149478_bb0080","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41591-025-03776-7","article-title":"Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial","volume":"31","author":"Song Yang","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0085","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): emerging therapeutic opportunities","volume":"628","author":"Hussein","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0090","article-title":"Reactive oxygen species (ROS): critical roles in breast tumor microenvironment","volume":"160","author":"RamaRao","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"32","key":"10.1016\/j.ijbiomac.2025.149478_bb0095","article-title":"Nanomedicine-driven modulation of reductive stress for cancer therapy","volume":"12","author":"Yumin","year":"2025","journal-title":"Adv. Sci."},{"issue":"307","key":"10.1016\/j.ijbiomac.2025.149478_bb0100","article-title":"MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes","volume":"307","author":"Yangyang","year":"2024","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149478_bb0105","article-title":"Reactive oxygen species of tumor microenvironment: harnessing for immunogenic cell death","volume":"1879","author":"RamaRao","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.redox.2015.07.008","article-title":"Antioxidant responses and cellular adjustments to oxidative stress","volume":"6","author":"Cristina","year":"2015","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0115","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1038\/s41598-017-03881-9","article-title":"The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells","volume":"7","author":"Chun","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.149478_bb0120","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0125","first-page":"57","article-title":"RhoA GTPase oxidation stimulates cell proliferation via nuclear factor-\u03baB activation, Free Radic","volume":"103","author":"Jae-Gyu","year":"2016","journal-title":"Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0130","article-title":"Integrating cell-signalling pathways with NF-kappaB and IKK function","volume":"8","author":"P. Neil","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Hui","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149478_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/cr.2008.31","article-title":"TNFalpha and reactive oxygen species in necrotic cell death","volume":"18","author":"Michael J","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0145","article-title":"Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies","volume":"165","author":"Xiaoting","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0150","article-title":"Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells","volume":"11","author":"Ze-Zhou","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0155","first-page":"1","article-title":"Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors","volume":"218","author":"Sophie","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","article-title":"Chapter three - reactive oxygen species and DNA damage response in cancer","volume":"364","author":"Renaudin","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12906-021-03225-1","article-title":"Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt\/mTOR signaling pathway","volume":"21","author":"Yuqin","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.149478_bb0170","article-title":"Advances in the preparation, stability, metabolism, and physiological roles of anthocyanins: a review","volume":"12","author":"Qi","year":"2023","journal-title":"Foods"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149478_bb0175","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/antiox12051004","article-title":"Oligomeric proanthocyanidins: an updated review of their natural sources, synthesis, and potentials","volume":"12","author":"Fanxuan","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10408390209351915","article-title":"Cranberry proanthocyanidins and the maintenance of urinary tract health","volume":"42","author":"Amy B","year":"2002","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149478_bb0185","article-title":"Procyanidins as potential anticancer agents: mechanisms of action, bioavailability challenges and therapeutic opportunities","volume":"42","author":"Adedayo O","year":"2025","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149478_bb0190","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/bgm198","article-title":"Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3","volume":"29","author":"Tomisato","year":"2007","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0195","article-title":"Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer","volume":"8","author":"Shusuke","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149478_bb0200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.nutres.2012.05.012","article-title":"Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling","volume":"32","author":"Shuangsheng","year":"2012","journal-title":"Nutr. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.149478_bb0205","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ptr.2781","article-title":"Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier","volume":"23","author":"Ling","year":"2009","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.149478_bb0210","article-title":"Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-\u03baB and MAPK\/ERK mediated YB-1 activity in A2780\/T cells","volume":"8","author":"Bo-xin","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0215","first-page":"836","article-title":"Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives","volume":"10","author":"Lin","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0220","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Daniel","year":"2018","journal-title":"Nat. Commun."},{"issue":"46","key":"10.1016\/j.ijbiomac.2025.149478_bb0225","article-title":"Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron\/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer","volume":"34","author":"Wenjuan","year":"2022","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149478_bb0230","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1021\/acsnano.3c02365","article-title":"Hybrid biomimetic membrane coated particles-mediated bacterial ferroptosis for acute MRSA pneumonia","volume":"17","author":"Huiqun","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0235","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Baharak","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149478_bb0240","article-title":"A physiologically responsive nanocomposite hydrogel for treatment of head and neck squamous cell carcinoma via proteolysis-targeting chimeras enhanced immunotherapy","volume":"35","author":"Yaping","year":"2023","journal-title":"Adv. Mater."},{"issue":"37","key":"10.1016\/j.ijbiomac.2025.149478_bb0245","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1039\/D2TB00709F","article-title":"Cell membrane-engineered nanoparticles for cancer therapy","volume":"10","author":"Wenjing","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.149478_bb0250","doi-asserted-by":"crossref","first-page":"24593","DOI":"10.1021\/acsnano.3c10212","article-title":"Advanced generation therapeutics: biomimetic nanodelivery system for tumor immunotherapy","volume":"17","author":"Jie","year":"2023","journal-title":"ACS Nano"},{"issue":"51","key":"10.1016\/j.ijbiomac.2025.149478_bb0255","article-title":"Precise subcellular organelle targeting for boosting endogenous-stimuli-mediated tumor therapy","volume":"33","author":"Wenyao","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0260","article-title":"Recent progress in targeted delivery vectors based on biomimetic nanoparticles","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0265","article-title":"Homologous-adhering\/targeting cell membrane- and cell-mediated delivery systems: a cancer-catch-cancer strategy in cancer therapy","volume":"12","author":"Chenguang","year":"2025","journal-title":"Regen. Biomater."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.149478_bb0270","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Inmaculada","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149478_bb0275","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1631\/jzus.B2200156","article-title":"Development and application of bionic systems consisting of tumor-cell membranes","volume":"23","author":"Tianjiao","year":"2022","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0280","article-title":"Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy","volume":"281","author":"Caili","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0285","article-title":"Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier","volume":"23","author":"Shengnan","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149478_bb0290","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1021\/acsabm.4c01737","article-title":"Periodate-mediated cross-linking for the preparation of catechol conjugated albumin nanoparticles used for in vitro drug delivery","volume":"8","author":"Eda","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0295","article-title":"Aggregation kinetics of UV irradiated nanoplastics in aquatic environments","volume":"163","author":"Yanjun","year":"2019","journal-title":"Water Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12951-025-03508-6","article-title":"Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy","volume":"23","author":"Jie","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0305","article-title":"Development, in vitro and ex vivo characterization of lamotrigine-loaded bovine serum albumin nanoparticles using QbD approach","volume":"32","author":"Maryana","year":"2025","journal-title":"Drug Deliv."},{"issue":"42","key":"10.1016\/j.ijbiomac.2025.149478_bb0310","doi-asserted-by":"crossref","first-page":"12207","DOI":"10.1021\/jp5081115","article-title":"Conformational change of bovine serum albumin molecules at neutral pH in ultra-diluted aqueous solutions","volume":"118","author":"Shulian","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.149478_bb0315","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Miguel","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.actbio.2022.12.058","article-title":"Systematic modulation of the lipid composition enables the tuning of liposome cellular uptake","volume":"158","author":"Ana","year":"2023","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149478_bb0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1756-9966-30-104","article-title":"Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells","volume":"30","author":"Yun","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149478_bb0330","first-page":"404","article-title":"Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress","volume":"3","author":"Sabry M","year":"2011","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0335","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.actbio.2025.07.026","article-title":"A supramolecular photopyroptosis nanoinducer with acidity-activatable immunomodulation for potentiating cancer immunotherapy","volume":"203","author":"Lingfei","year":"2025","journal-title":"Acta Biomater."},{"issue":"45","key":"10.1016\/j.ijbiomac.2025.149478_bb0340","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","article-title":"Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: effects of experimental conditions and electrokinetic models on the interpretation of results","volume":"37","author":"Daniel Jos\u00e9","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2025.149478_bb0345","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijbiomac.2022.01.029","article-title":"Crosslinkers for polysaccharides and proteins: synthesis conditions, mechanisms, and crosslinking efficiency, a review","volume":"202","author":"Carvalho","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"48","key":"10.1016\/j.ijbiomac.2025.149478_bb0350","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1021\/acs.jpcb.1c08044","article-title":"Effect of phosphatidylethanolamine and oleic acid on membrane fusion: phosphatidylethanolamine circumvents the classical stalk model","volume":"125","author":"Ankita","year":"2021","journal-title":"J. Phys. Chem. B"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025100354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025100354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T21:01:47Z","timestamp":1768942907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025100354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":70,"alternative-id":["S0141813025100354"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149478","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cell membrane-biomimetic and antioxidant-powered nanoplatform for overcoming multidrug resistance in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149478"}}